ACE and peripheral arterial disease: The use of statins and certain antihypertensive drugs such as angiotensin-converting enzyme inhibitors or angiotensin receptor blockers was reported to be associated with a slower progression of renal function and reduced cardiovascular risk in patients with PAD [49, 50].